d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI)
Authors:
Open Access
- 19 February 2024
- journal article
- review article
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 89 (4) , 284-294
Abstract
Background: d-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders. Objectives: This perspective seeks to explore the mechanisms and functions of d-chiro-inositol, laying the foundations to discuss its use in clinical practice, across dysmetabolism, obesity, and hormonal dysregulation. Methods: A narrative review of all the relevant papers known to the authors was conducted. Outcome: d-Chiro-inositol acts through a variety of mechanisms, acting as an insulin sensitizer, inhibiting the transcription of aromatase, in addition to modulating white adipose tissue/brown adipose tissue transdifferentiation. These different modes of action have potential applications in a variety of therapeutic fields, including PCOS, dysmetabolism, obesity, hypoestrogenic/hyperandrogenic disorders, and bone health. Conclusions: d-Chiro-inositol mode of action has been studied in detail in recent years, resulting in a clear differentiation between d-chiro-inositol and its isomer myo-inositol. The insulin-sensitizing activities of d-chiro-inositol are well understood; however, its potential applications in other fields, in particular obesity and hyperestrogenic/hypoandrogenic disorders in men and women, represent promising avenues of research that require further clinical study.Keywords
This publication has 86 references indexed in Scilit:
- Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysisIrish Journal of Medical Science (1971 -), 2023
- Inositol supplementation and body mass index: A systematic review and meta‐analysis of randomized clinical trialsObesity Science & Practice, 2021
- Drugs Causing Bone Loss2019
- Inositol, neural tube closure and the prevention of neural tube defectsBirth Defects Research, 2017
- A pilot study of d-chiro-inositol plus folic acid in overweight patients with type 1 diabetesActa Diabetologica, 2016
- Potential role and therapeutic interests of myo-inositol in metabolic diseasesBiochimie, 2013
- Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal womenEuropean Journal of Nutrition, 2012
- Understanding obesity and endometrial cancer risk: opportunities for preventionAmerican Journal of Obstetrics and Gynecology, 2011
- Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formationJournal of Bone and Mineral Research, 2010
- Variants in hormone biosynthesis genes and risk of endometrial cancerCancer Causes & Control, 2008